Matteo S. Carlino
Expertise in
4
conditions

Matteo S. Carlino

Cnr Hawkesbury Road And Darcy Road, 
Westmead, NSW, AU 
Expertise in
4
conditions
Cnr Hawkesbury Road And Darcy Road, 
Westmead, NSW, AU 

Overview

Matteo Carlino practices practicing medicine in Westmead, Australia.

Mr. Carlino is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Lung Metastases, Stent Placement, and Transcatheter Aortic Valve Replacement (TAVR).

He is actively involved in clinical research, co-authoring 284 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Cnr Hawkesbury Road And Darcy Road, Westmead, NSW 2145, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II, Randomised, Open Label Study of Neoadjuvant Dabrafenib, Trametinib and / or Pembrolizumab in BRAF V600 Mutant Resectable Stage IIIB/C/D (Excluding In-transit) Melanoma
A Phase II, Randomised, Open Label Study of Neoadjuvant Dabrafenib, Trametinib and / or Pembrolizumab in BRAF V600 Mutant Resectable Stage IIIB/C/D (Excluding In-transit) Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drugs: Dabrafenib, Trametinib, Pembrolizumab
Study Phase: Phase 2
Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
Enrollment Status: Completed
Publish Date: May 29, 2026
Intervention Type: Drug
Study Drugs: Matched targeted therapy, Trametinib, CDK4/6+MEK inhibitor, Compassionate Access Targeted Therapy
Study Phase: Phase 2
A Phase 1a/1b, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of AK119 in Combination With AK104 in Subjects With Advanced or Metastatic Solid Tumors.
A Phase 1a/1b, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of AK119 in Combination With AK104 in Subjects With Advanced or Metastatic Solid Tumors.
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Biological
Study Phase: Phase 1
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Radiation, Drug
Study Drug: Dabrafenib and Trametinib (Combination)
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

284 Total Publications

Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications.
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 25, 2026

Frequently Asked Questions about Matteo S. Carlino

Is Matteo S. Carlino a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Matteo S. Carlino is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Matteo S. Carlino participate in research or clinical trials?

Yes. Matteo S. Carlino has published 284 articles and abstracts on conditions like Melanoma. You can view a list of Matteo S. Carlino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Carlino's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile